MSTN and muscle atrophy: Additional clinical data on patients with muscle atrophy-linked neuromuscular disorders reveal that patients with advanced muscle wasting and atrophy have significant decreases in circulating myostatin levels and myostatin expression in muscle biopsies (Burch et al., 2017; Mariot et al., 2017) in contrast to other studies (Brandt et al., 2012).